One more under-$10 stock in the biotechnology and drugs complex that's trading within range of a major breakout trade is
, which is involved in collecting, storing, manufacturing, therapeutic developing, and transporting cells for cell based medicine and regenerative science. This stock has been on fire so far in 2012, with shares up over 40%.
If you take a look at the chart for Neostem, you'll notice that this stock has been uptrending very strong for the past six months, with shares skyrocketing from a low of 30 cents per share to its August high of 84 cents per share. During that strong uptrend, shares of NBS have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed NBS within range of triggering a major breakout trade.
Traders should now look for long-biased trades in NBS once it manages to break out above some near-term overhead resistance levels at 75 to 84 cents per share, and then above its 52-week high of 90 cents per share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1,228,630 shares. If that breakout hits soon, then NBS could re-test or possibly take out its next major overheard resistance levels at 96 cents to $1.50 a share.
Traders can look to buy NBS off weakness and simply anticipate that breakout, with a stop that sits just below its 50-day moving average of 66 cents per share. You could even give NBS room down towards 58 cents per share if you get long off a large pullback. One could also buy NBS off strength once it takes out 75 cents to 84 cents, and then use a stop just below 75 to 70 cents per share. I would add aggressively to NBS once it clears 90 to 96 cents per share with volume.
To see more hot under-$10 equities, check out the
Stocks Under-$10 Setting Up To Explode
portfolio on Stockpickr.
-- Written by Roberto Pedone in Winderemere, Fla.
Follow Stockpickr on
and become a fan on